Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study
暂无分享,去创建一个
M. Schaller | D. Sarwer | A. Bewley | B. Homey | N. Kerrouche | M. Hofmann | P. Lehmann | C. Nohlgård | A. Layton | Y. Ma